Press
Press
Episode 18: Investing in Startup Companies with Neil Littman
Neil Littman is the CEO and Founder of Bioverge Inc. Bioverge is an investment platform that funds visionary entrepreneurs with the aim of transforming healthcare and bringing science fiction to life. In this episode of MedStreet Journal, Neil Littman shares what he’s working on in Bioverge, his experiences in the healthcare industry and how it led him towards creating a company with an entrepreneurial management team skilled in venture creation as well as science.
Continue Reading >
Press
Episode #146: Neil Littman, Bioverge, “The More Risk You Kill, Inherently, The More Value You Create”
Podcast link: https://mebfaber.com/2019/03/13/episode-146-neil-littman-the-more-risk-you-kill-inherently-the-more-value-you-create/ Neil Littman is the Founder of Bioverge, a highly curated impact investment platform exclusively dedicated to healthcare. Bioverge enables a motivated public to finance and support the health-related causes and companies most important to them. Previously, Neil was a member of the Executive Leadership Team and Director ...
Continue Reading >
Press
Neil Littman of Bioverge: 5 Things I Need To See Before Making A VC Investment
As part of our series about “5 Things I Need To See Before Making A VC Investment”, I had the pleasure of interviewing Neil J. Littman, MS. He has comprehensive healthcare-specific financial experience in venture capital, business development, and investment banking. As a member of the Executive Leadership Team and ...
Continue Reading >
Press
Will new equity crowdfunding rules boost health care startups? One S.F. firm is betting on it.
Even as venture capital last year poured $28.5 billion into biotech companies globally and biotech IPOs raised more than $5 billion in the first quarter of this year alone, Neil Littman says he saw both a disturbing trend, as well as a potential opportunity. Investors focused more capital into larger ...
Continue Reading >
Press
Managed marketplaces and reality TV: How a new generation of gatekeepers is opening biotech up to amateur investors
Starton Therapeutics, a drug delivery biotech, is raising its next round of capital through Unicorn Hunters, a streaming show that invites viewers to consider and invest in a variety of startups alongside a panel of celebrity investors.
Continue Reading >
Health + Tech, Investing, Press
Investment Opportunity, You Can Now Invest In Bioverge!
The Bioverge Reg CF Offering is Officially Live 🎊 and Accepting Investments!
Continue Reading >